GO
Loading...

Enter multiple symbols separated by commas

Celgene Corp

More

  • Treehouse Foods and Sony are big market movers Tuesday, 30 Jun 2015 | 4:25 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:. Treehouse Foods Inc., up $6.89 to $81.03. Willis Group Holdings PLC, up $1.50 to $46.90.

  • June 30- U.S. stocks shed some of their early gains on Tuesday as nervous investors wondered whether last-minute talks would produce a bailout deal that would keep Greece in the euro. German Chancellor Angela Merkel told lawmakers she did not expect any new developments, appearing to dash hopes of a deal before Greece defaults on a 1.6 billion euro payment to the...

  • Celgene, Juno map out cancer treatment collaboration Tuesday, 30 Jun 2015 | 9:44 AM ET

    Shares of Juno Therapeutics soared Tuesday morning, a day after larger drug developer Celgene announced plans to invest about $1 billion in Juno mostly through stock purchases as part of a collaboration to develop cancer and autoimmune disease treatments. Celgene will pay about $150 million upfront and buy 9.1 million shares of Juno's common stock at $93...

  • June 30- Wall Street was set to open higher on Tuesday, a day after the Dow and the S&P 500 registered their worst session since October, as investors hoped Greece would strike a last-minute deal to avoid an exit from the euro zone. Greece is hours away from defaulting on a 1.6 billion euro repayment to the International Monetary Fund. U.S. corporations have limited...

  • Celgene places $1B bet on Juno Therapeutics Tuesday, 30 Jun 2015 | 1:45 AM ET

    Biotech giant Celgene has invested $1 billion in Juno Therapeutics in a move to that backs experimental cancer treatments, the FT reports.

  • Your first trade for Tuesday Monday, 29 Jun 2015 | 6:19 PM ET
    Fast Money Final Trade:  COST, NXPI, RNF & SAVE

    The "Fast Money" traders give their final trades of the day.

  • After-hours buzz: Juno, Apollo Education & more Monday, 29 Jun 2015 | 5:35 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Check out the companies making headlines after the bell Monday: Juno, Apollo Education & more.

  • June 29- Celgene Corp said it would invest about $1 billion in Juno Therapeutics Inc to partner in the development and marketing of immunotherapies for the treatment of cancer and autoimmune diseases. Celgene will pay Juno about $150 million upfront and buy about 10 percent of Juno's shares at $93 each, almost double of Juno's closing price on Monday.

  • June 29- Celgene Corp and Juno Therapeutics Inc said they signed a deal to develop and commercialize immunotherapies for the treatment of cancer and autoimmune diseases. Juno will receive about $150 million upfront, and will sell 9.1 million shares of its common stock at $93 each to Celgene, the companies said on Monday. Shares of Juno were up 61 percent in...

  • June 29- Celgene Corp and Juno Therapeutics Inc said they signed a deal to develop and commercialize immunotherapies for the treatment of cancer and autoimmune diseases. Juno will receive about $150 million upfront, and will sell 9.1 million shares of its common stock at $93 each to Celgene, the companies said on Monday. Shares of Juno were up 61 percent in...

  • Portfolio Playbook: Buy the chips Thursday, 18 Jun 2015 | 3:23 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Portfolio Playbook: Buy the chips

  • Lightning Round: Huge deals ahead for this group Wednesday, 17 Jun 2015 | 7:59 PM ET
    Mad Money Lightning Round

    Jim Cramer sees that this group is ready for some major deals, as he gives his take on caller favorite stocks.

  • As tech stocks stall, these names may break out Wednesday, 10 Jun 2015 | 1:55 PM ET

    Technology, one of the hottest areas in the six-year bull market has hit a standstill in 2015. Here are the stocks that could buck the trend.

  • After-hours buzz: Five Below, FireEye & more Wednesday, 3 Jun 2015 | 5:48 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Check out the companies making headlines after the bell Wednesday: Five Below, FireEye & more.

  • After BMY's drop, cancer drug stocks set to move? Monday, 1 Jun 2015 | 5:00 AM ET
    Attendees walk through the lobby at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. (File Photo).

    The stock-moving news flow started early out of the American Society of Clinical Oncology meeting in Chicago.

  • Biotech investors up big amid bubble talk Thursday, 28 May 2015 | 9:56 AM ET
    Biotech

    Some view skyrocketing biotech stocks as a bubble, but hedge funds are riding optimism in the sector to monster gains—for now.

  • Here's how to play weak Q2 earnings season Monday, 18 May 2015 | 7:39 AM ET
    Delta Airlines planes sit at Terminal 4 at John F. Kennedy Airport in New York.

    Negative revenue growth will continue to dog investors in Q2 and Q3, analyst Mike Thompson says. Here's what to do about it.

  • This biotech stock is a bargain: Strategist Wednesday, 13 May 2015 | 2:45 PM ET
    Biotech

    Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers.

  • Investors were waiting for news that could move share prices from many bigger companies including Bristol-Meyers Squibb Co, Amgen Inc and Celgene Corp. Hot topics at the American Society of Clinical Oncology conference in Chicago will include immuno oncology and CAR-T cell therapies. Shares in Juno Therapeutics Inc, Kite Pharma Inc, BlueBird Bio Inc and...

  • May 6- The hefty premium Alexion Pharmaceuticals Inc has agreed to pay to acquire Synageva BioPharma Corp highlights how the popularity of so-called orphan drug makers is leading to valuations many investors now deem frothy. Other recent big deals involving orphan drug makers that focus on rare diseases include Teva Pharmaceutical Industries Ltd's $3.5...